Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Carr

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2010
European development of clofarabine as treatment for older patients with acute myeloid leukemia considered unsuitable for intensive chemotherapyAlan K Burnett, Nigel H Russell, Jonathan Kell, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 13, 2014
Combined PET and biopsy evidence of marrow involvement improves prognostic prediction in diffuse large B-cell lymphomaJuliano J Cerci, Tamás Györke, Stefano Fanti, et al.
Clinical Pharmacology and Therapeutics|March 4, 2006
Organic anion transporting polypeptide 1B1 activity classified by SLCO1B1 genotype influences atrasentan pharmacokineticsDavid A Katz, Robert Carr, David R Grimm, et al.
Leukemia & Lymphoma|October 12, 2016
The effect of biological heterogeneity on R-CHOP treatment outcome in diffuse large B-cell lymphoma across five international regionsRobert Carr, Hilal Ozdag, Nilgun Tekin, et al.
Acta Haematologica|March 19, 2020
Identification of a Patient Cohort with Relapsing Diffuse Large B-Cell Lymphoma with a Low International Prognostic Index in PET/CT Using a 2-Gene (LMO2/TNFRSF9) Scoring SystemNader Omidvar, Nilgun Tekin, Paulette Conget, et al.
Oncotarget|November 9, 2016
Protocol for qRT-PCR analysis from formalin fixed paraffin embedded tissue sections from diffuse large b-cell lymphoma: Validation of the six-gene predictor scoreNilgun Tekin, Nader Omidvar, Tim Peter Morris, et al.
British Journal of Pharmacology|June 17, 2026
In silico prediction of novel effective combinational treatment of chronic pain in individual patients: A joint white paper of the H2020 QSPainRelief consortiumAndré Mouraux, Solenn Gousset, Beltrán Alvarez, et al.
Science Translational Medicine|March 15, 2019
Preclinical development of an oral anti-<i>Wolbachia</i> macrolide drug for the treatment of lymphatic filariasis and onchocerciasisMark J Taylor, Thomas W von Geldern, Louise Ford, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 18, 2020
IMI - Oral biopharmaceutics tools project - Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling strategiesAmais Ahmad, Xavier Pepin, Leon Aarons, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2010
European development of clofarabine as treatment for older patients with acute myeloid leukemia considered unsuitable for intensive chemotherapyAlan K Burnett, Nigel H Russell, Jonathan Kell, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 13, 2014
Combined PET and biopsy evidence of marrow involvement improves prognostic prediction in diffuse large B-cell lymphomaJuliano J Cerci, Tamás Györke, Stefano Fanti, et al.
Clinical Pharmacology and Therapeutics|March 4, 2006
Organic anion transporting polypeptide 1B1 activity classified by SLCO1B1 genotype influences atrasentan pharmacokineticsDavid A Katz, Robert Carr, David R Grimm, et al.
Leukemia & Lymphoma|October 12, 2016
The effect of biological heterogeneity on R-CHOP treatment outcome in diffuse large B-cell lymphoma across five international regionsRobert Carr, Hilal Ozdag, Nilgun Tekin, et al.
Acta Haematologica|March 19, 2020
Identification of a Patient Cohort with Relapsing Diffuse Large B-Cell Lymphoma with a Low International Prognostic Index in PET/CT Using a 2-Gene (LMO2/TNFRSF9) Scoring SystemNader Omidvar, Nilgun Tekin, Paulette Conget, et al.
Oncotarget|November 9, 2016
Protocol for qRT-PCR analysis from formalin fixed paraffin embedded tissue sections from diffuse large b-cell lymphoma: Validation of the six-gene predictor scoreNilgun Tekin, Nader Omidvar, Tim Peter Morris, et al.
British Journal of Pharmacology|June 17, 2026
In silico prediction of novel effective combinational treatment of chronic pain in individual patients: A joint white paper of the H2020 QSPainRelief consortiumAndré Mouraux, Solenn Gousset, Beltrán Alvarez, et al.
Science Translational Medicine|March 15, 2019
Preclinical development of an oral anti-<i>Wolbachia</i> macrolide drug for the treatment of lymphatic filariasis and onchocerciasisMark J Taylor, Thomas W von Geldern, Louise Ford, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 18, 2020
IMI - Oral biopharmaceutics tools project - Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling strategiesAmais Ahmad, Xavier Pepin, Leon Aarons, et al.
Pageof 5